Varda Space Industries has raised $187M in Series C funding to scale its space-based pharmaceutical manufacturing efforts. The round supports a new 10,000 sqft lab for biologics like monoclonal antibodies and plans to increase mission cadence. Varda has successfully completed three missions to date, with a fourth currently in orbit and a fifth planned by year-end. Their edge lies in microgravity manufacturing and hypersonic reentry, two core enablers of the orbital pharma economy. NatCapCentral and ShrugCap led the investment.
- Company
- Varda Space varda.com
- Round
- Series C
- Amount
- $187M
- Source
- prnewswire.com
- In the newsletter
- No. 182, Mapping U.S. Manufacturing MegaProjects